Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
News Focus
Safe Supply Announces Signing of Definitive Agreement to Acquire Drug Lab 118 (click to learn more)
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Theralase Technologies Inc. V.TLT

Alternate Symbol(s):  TLTFF

Healthcare Medical Devices
Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.


TSXV:TLT - Post by User

Theralase Technologies Inc. > Bladder Cancer Canada case
<< Previous
 Bullboard Posts
Next >>
User Avatar Image
(20)
•••
Comment by skyhawk1on Jun 18, 2023 10:39am
193 Views
Post# 35502380

RE:RE:Bladder Cancer Canada case

RE:RE:Bladder Cancer Canada case

Pandora ~ so sorry to hear that. We went through a very similar ordeal with my 'dear (beautiful, wondeful) mommy' with a heart of gold!!


She was our family MATRIACH so full of wisedom & kindness & respect to everyone who knew her!


That's why Theralase is such an emotional investment for so many 'super longs'! My family & I are here to the very end ONLY because of her!
 

There seems to be so much money being raised & donated into cancer research with little to show for it in terms of actual & successful cancer treatment?!


Even though this investment can be very frustrating at times, we believe that Theralase STILL seems to be our only 'beacon of hope' for a successful cancer treatment to stop the suffering for millions?!


PANDORA ~ keep WALKING & good day y'all 



 

<< Previous
 Bullboard Posts
Next >>
Dealroom for high-potential pre-IPO opportunities